Cerepharma SA
6.3 FTECerepharma reported total assets of €1.52m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Apr 2026), with 6.3 full-time equivalents.
The score of Cerepharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +53 % Total assets -3 % Headcount (avg FTE) +12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cerepharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 91,805 € | ||||
| Equity | 933,614 € | ||||
| Cash | 182,832 € | ||||
| EBITDA | 254,316 € | ||||
| Total assets | €1.52m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 26 Apr 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
- Year ended 30 Sep 2023filed on 26 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
Cerepharma's financial analysis
- Solvency61.2%sector median: 61.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cerepharma
Cerepharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0834.075.086
- VAT number
- BE0834075086
- Peppol
- Registered · 0208:0834075086 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Feb 2011
- Registered office
- 7822 Ath
- Size
- Micro · 6.3 FTE
- Latest accounts
- 2025 · filed on 26 Apr 2026
- Activity
- Manufacture of perfume and toilet preparations (NACE 20420)
Cerepharma (SA) has been based in Ath since 2011, active in: manufacture of perfume and toilet preparations. For 2025, it reports a net profit of 91,805 € and equity of 933,614 €; its revenue is not published. With 6.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 61.2%, above the median of its sector (61.2%).
Companies similar to Cerepharma
Companies in the same business, of comparable size and area, outside its group.
- Laboratoire DIPO Manufacture of perfume and toilet preparations Etterbeek · balance sheet 24,259 €
- Apotheke Reul Retail sale of pharmaceutical products Eupen · balance sheet €1.44m
- Pharmacie Smits Manufacture of pharmaceutical preparations Wavre · balance sheet €1.86m
- D2S Pharma Manufacture of basic pharmaceutical products Oudenaarde · balance sheet 582,318 €
- Feton International Wholesale of pharmaceutical and medical goods La Louvière · balance sheet €1.39m
- Laboratoires DE Biarritz International Manufacture of perfume and toilet preparations Waterloo · balance sheet €2.34m
- LABO DéESSE Manufacture of perfume and toilet preparations Beveren-Kruibeke-Zwijndrecht · balance sheet 799,197 €
- Lophar Retail sale of pharmaceutical products Aalter · balance sheet €1.33m
Frequently asked questions about Cerepharma
What is the revenue of Cerepharma?
Cerepharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cerepharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0834075086 for Cerepharma, if the company is VAT-registered. Its company number (CBE) is 0834.075.086.
Where is the registered office of Cerepharma?
According to the CBE register, the registered office of Cerepharma is in 7822 Ath.
What is the equity of Cerepharma?
At the close of the 2025 financial year, the equity of Cerepharma amounts to 933,614 €, a solvency of 61.2% of total assets.
How many people work at Cerepharma?
6.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cerepharma?
The register lists 5 active mandates at Cerepharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cerepharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →